Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
67.7M
-
Shares change
-
-2.9M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
-$93.7M
-
Put/Call ratio
-
0.77
-
Number of buys
-
81
-
Number of sells
-
-100
-
Price
-
$26.63
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2021
246 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.7M shares
of 101M outstanding shares and own 67.1% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (12.5M shares), VANGUARD GROUP INC (7.89M shares), BlackRock Inc. (7.24M shares), HHLR ADVISORS, LTD. (3.96M shares), FMR LLC (3.63M shares), STATE STREET CORP (3.42M shares), FIRST TRUST ADVISORS LP (3.11M shares), JPMORGAN CHASE & CO (2.25M shares), Bank of New York Mellon Corp (2.14M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.5M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.